The evolving landscape of the economics of HIV treatment and prevention

PLoS Medicine

Volumn 9, Issue 2, 2012, Pages

  Nosyk, Bohdan ^a   Montaner, Julio S G ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROL STRATEGY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; VIRUS TRANSMISSION; COST BENEFIT ANALYSIS; ECONOMICS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COST-BENEFIT ANALYSIS; HIV INFECTIONS; HUMANS;

EID: 84857744251     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001174     Document Type: Article

References (19)

1. UNAIDS (2010) UNAIDS report on the global AIDS epidemic 2010. Available: http://www.unaids.org/globalreport/global_report.htm. Accessed 10 September 2011.
2. Lomborg B, Piot P, (27 September 2011) Re-thinking the fight against AIDS. Wall Street Journal Online. Available: http://online.wsj.com/article/SB10001424053111904194604576583071258290228.html?KEYWORDS=HIV. Accessed 27 September 2011.
3. Fauci AS, (2011) AIDS: Let science inform policy. Science 333: 13.
4. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
5. Wood E, Kerr T, Marshall BD, Li K, Zhang R, et al. (2009) Longitudinal community plasma HIV-1-RNA concentrations and incidence of HIV-1 among injecting drug users: a prospective cohort study. BMJ 338: b1649.
6. Kirk G, Galai N, Astemborski J, Linas B, Celentano D, et al. (2011) Decline in community viral load strongly associated with declining HIV incidence among IDU. Abstract 484. 18th Conference on Retroviruses and Opportunistic Infections; 27 February-2 March; Boston, Massachusetts.
7. Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. Lancet 376: 532-539.
8. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, et al. (2010) Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE 5: e11068 doi:10.1371/journal.pone.0011068.
9. Walensky RP, Freedberg KA, Weinstein MC, Paltiel AD, (2007) Cost-effectiveness of HIV testing and treatment in the United States. Clin Infect Dis 45: S248-S254.
10. Walensky RP, Paltiel AD, Freedberg KA, (2002) AIDS drug assistance programs: highlighting inequalities in human immunodeficiency virus-infection health care in the United States. Clin Infect Dis 35: 606.
11. Duff P, Kipp W, Wild TC, Rubaale T, Okech-Ojony J, (2010) Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc 13: 37.
12. Hornberger J, Holodniy M, Robertus K, Winnike M, Gibson E, et al. (2007) A systematic review of cost-utility analyses in HIV/AIDS: Implications for public policy. Med Decis Making 27: 789-821.
13. Johnston KM, Levy AR, Lima VD, Hogg RS, Tyndall MW, et al. (2010) Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS 24: 1929-1935.
14. Badri M, Wilson D, Wood R, (2002) Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359: 2059-2064.
15. Bhagarva A, Bigombe B, (2003) Public policies and the orphans of AIDS in Africa. BMJ 326: 1387-1389.
16. Dixon S, McDonald S, Roberts J, (2002) The impact of HIV and AIDS on Africa's economic development. BMJ 324: 232-234.
17. Walensky RP, Paltiel AD, Losina E, Morris B, Scott AS, et al. (2010) Test and Treat DC: forecasting the impact of a comprehensive HIV strategy in Washington, DC. Clin Infect Dis 51: 392-400.
18. Miller WC, Rosenberg NE, Rutstein SE, Powers KA, (2010) Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS 5: 277-282.
19. Volkow N, Montaner J, (2010) Enhanced HIV testing, treatment, and support for HIV-infected substance users. JAMA 303: 1423-1424.